Recombinant Human CD40 Ligand/TNFSF5 (HEK293-expressed), CF 6420-CLB-050 from R&D Systems, a Bio-Techne Brand

Product Specs
ItemRecombinant Human CD40 Ligand/TNFSF5 (HEK293-expressed), CF
CompanyR&D Systems, a Bio-Techne Brand
Price $384.00Supplier Page View Company Product Page
Catalog Number6420-CLB-050
ApplicationsBioactivity
Size50 ug
NCBI Full Gene NameCD40 ligand
NCBI Gene AliasesIMD3, HIGM1, gp39, CD40L, CD154, TNFSF5, hCD40L, IGM, T-BAM, TRAP
SpeciesHuman
FormatLyophilized from a 0.2 µm filtered solution in PBS and EDTA with Trehalose
Conjugate/TagUnconjugated
Purity>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
Molecule NameCD40 Ligand/TNFSF5
Source/Expression SystemHEK293-derived Recombinant Human CD40 Ligand/TNFSF5 (HEK293-expressed), CF
Molecular WeightObserved: 20-27 kDa, under reducing conditions.
Theoretical: 22 kDa
StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution

614 McKinley Place N.E.

Minneapolis, Minnesota 55413

United States

Phone: 1 (800) 343-7475
1 (612) 379-2956

Fax: 1 (612) 656-4400

(2) Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic targetBlood cancer journalMay 2, 2024Dobaño-López C, Valero JG, Araujo-Ayala F, Nadeu F, Gava F, Faria C, Norlund M, Morin R, Bernes-Lasserre P, Arenas F, et al.

(3) Chromatin Landscape Underpinning Human Dendritic Cell HeterogeneityCell reportsSeptember 22, 2020Leylek R, Alcántara-Hernández M, Granja JM, Chavez M, Perez K, Diaz OR, Li R, Satpathy AT, Chang HY, Idoyaga J.

(4) Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphateNature communicationsJuly 8, 2020Bibby JA, Purvis HA, Hayday T, Chandra A, Okkenhaug K, Rosenzweig S, Aksentijevich I, Wood M, Lachmann HJ, Kemper C, et al.

(5) Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light ChainJournal of the American Heart AssociationFebruary 4, 2020Kojok K, Mohsen M, El Kadiry AEH, Mourad W, Merhi Y.

(6) CD24^hiCD38^hi and CD24^hiCD27⁺ Human Regulatory B Cells Display Common and Distinct Functional CharacteristicsJournal of immunology (Baltimore, Md. : 1950)October 15, 2019Hasan MM, Thompson-Snipes L, Klintmalm G, Demetris AJ, O'Leary J, Oh S, Joo H.

(7) An essential role for the Zn²⁺ transporter ZIP7 in B cell developmentNature immunologyMarch 1, 2019Anzilotti C, Swan DJ, Boisson B, Deobagkar-Lele M, Oliveira C, Chabosseau P, Engelhardt KR, Xu X, Chen R, Alvarez L, et al.

(8) An anti-TL1A antibody for the treatment of asthma and inflammatory bowel diseasemAbsMay 1, 2018Clarke AW, Poulton L, Shim D, Mabon D, Butt D, Pollard M, Pande V, Husten J, Lyons J, Tian C, et al.

(10) Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis opticaBrain : a journal of neurologyApril 1, 2018Wilson R, Makuch M, Kienzler AK, Varley J, Taylor J, Woodhall M, Palace J, Leite MI, Waters P, Irani SR.

(12) EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCLMolecular cancer therapeuticsNovember 1, 2017Brach D, Johnston-Blackwell D, Drew A, Lingaraj T, Motwani V, Warholic NM, Feldman I, Plescia C, Smith JJ, Copeland RA, et al.

(14) CD40L-Dependent Pathway Is Active at Various Stages of Rheumatoid Arthritis Disease ProgressionJournal of immunology (Baltimore, Md. : 1950)June 1, 2017Guo Y, Walsh AM, Fearon U, Smith MD, Wechalekar MD, Yin X, Cole S, Orr C, McGarry T, Canavan M, et al.

(15) Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infectioneLifeApril 20, 2017Price AM, Dai J, Bazot Q, Patel L, Nikitin PA, Djavadian R, Winter PS, Salinas CA, Barry AP, Wood KC, et al.

(16) TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cellsEuropean journal of immunologyJuly 1, 2014Liu BS, Cao Y, Huizinga TW, Hafler DA, Toes RE.

(18) Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitorsNatureJuly 26, 2012Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, et al.

(19) B cells as a therapeutic target for IFN-β in relapsing-remitting multiple sclerosisJournal of immunology (Baltimore, Md. : 1950)April 1, 2011Ramgolam VS, Sha Y, Marcus KL, Choudhary N, Troiani L, Chopra M, Markovic-Plese S.

CD40 Ligand/TNFSF5 Protein